Digilogic Systems (544684)
Slow GrowerScore breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹91.5 |
| Market Cap | ₹264.9 Cr |
| P/E Ratio | 34.14 |
| ROCE | 34.98% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| Sector | Aerospace & Defense |
Strengths
- ROCE of 34.98% indicates strong return on capital employed.
- Latest quarter shows profitability: ₹2 crore net profit on ₹18 crore sales, an approximate 11% net margin.
- P/E of 34.14 implies trailing earnings of around ₹7.8 crore, so the company is genuinely profitable.
- Operating in aerospace and defense gives it a niche industrial positioning.
Concerns
- Sales growth and profit growth are both 0.00%, yet the stock trades at 34.14 times earnings.
- Piotroski F-Score of 3/9 signals weak financial health.
- Dividend yield is 0.00%, so investors receive no income while waiting for growth.
- Critical data is missing: no book value, ROE, debt-to-equity, promoter holding, or 52-week range.
AI Analysis
At ₹91.50, Digilogic Systems carries a market cap of ₹265 crore. Dividing by the P/E of 34.14, I infer trailing earnings of roughly ₹7.8 crore. The latest quarter adds ₹2 crore net profit on ₹18 crore sales, so the run-rate is consistent. My first thought is the 34.98% ROCE. That is genuinely excellent. It suggests capital is being deployed efficiently, and in aerospace and defense, that may indicate a niche or pricing power. But then I stop. Sales growth is 0.00% and profit growth is 0.00%. I am not in the habit of paying 34 times earnings for a business with no growth. The Piotroski F-Score is 3 out of 9, a serious red flag about financial health. There is no dividend, so the only reward must come from price appreciation. At this valuation, Mr Market has already priced in future success. Worse, the data is incomplete: no book value, no return on equity, no debt-to-equity ratio, no promoter holding. Benjamin Graham taught me to demand adequate information; without it, I cannot assess the margin of safety. A high ROCE is helpful, but it is not enough. For a zero-growth, high-multiple company, the downside feels real. The sales are small — one quarter of ₹18 crore suggests an annual scale of ₹72 crore — and the company is therefore vulnerable to order lumpiness. This looks like a business to study, not to buy. In the end, price is what you pay and value is what you get. At ₹91.50, I do not see the value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer